J. Walker

发表

Double-blind study of lorazepam and diazepam in status epilepticus.

R. Ramsay, R. Homan, I. Leppik, 1983, JAMA.

Amantadine and levodopa in the treatment of Parkinson's disease

J. Albers, W. Tourtellotte, A. Potvin, 1972, Clinical pharmacology and therapeutics.

HLA and the response of lymphocytes to viral antigens in patients with multiple sclerosis.

J. Cook, P. Stastny, J. Walker, 1982, Human immunology.

Dimethyl aminoethanol in Huntington's chorea.

J. Walker, J. Lewis, M. Hoehn, 1973, Lancet.

Tumor rejection in experimental animals treated with radioprotective thiols.

J. Walker, C. Apffel, S. Issarescu, 1975, Cancer research.

Falls and Fear of Falling Among Elderly Persons Living in the Community: Therapy Interventions

J. Howland, J. Walker, 2015 .

Hypoglycorrhachia associated with subarachnoid hemorrhage.

B. Troost, M. Cherington, J. Walker, 1968, Archives of neurology.

Quantitative evaluation of neuropharmacological trials

R. Pew, J. Albers, W. Tourtellotte, 1974, Clinical pharmacology and therapeutics.

Cyclic nucleotides in the amygdala of the kindled rat

J. Walker, I. Crawford, J. Mikeska, 1981, Brain Research Bulletin.

Plasmapheresis in multiple sclerosis

J. Walker, R. Tindall, J. Rollins, 1982, Neurology.

Lymphocytotoxic antibodies in multiple sclerosis.

H. Weiner, K. Mcintosh, J. Walker, 1977, Clinical immunology and immunopathology.

Aminophylline seizures in the rat

J. E. Walker, J. Walker, 1981, The Journal of pharmacy and pharmacology.

Predicting physical and verbal aggression on a brain trauma unit.

T. Galski, R. L. Bruno, J. Walker, 1994, Archives of physical medicine and rehabilitation.

Pirfenidone for chronic progressive multiple sclerosis

J. Walker, S. Margolin, Jonathan E. Walker, 2001, Multiple sclerosis.

Tricyclic antidepressant poisoning. Reversal of coma, choreoathetosis, and myoclonus by physostigmine.

B. Rumack, J. Ott, J. Burks, 1974, JAMA.

Lack of effect of diphenylhydantoin administration on cortex potassium activated p-nitrophenylphosphatase.

J. Walker, E. Lewin, V. Bleck, 1973, Neuropharmacology.

In vivo and in vitro availability of commercial warfarin tablets.

J. Wagner, P. Welling, J. Walker, 1971, Journal of pharmaceutical sciences.

Continuous intravenous vasopressin in active upper gastrointestinal bleeding.

D. Stein, P. Gregory, J. Walker, 1982, Annals of internal medicine.

POSSIBLE DIAGNOSTIC TEST FOR CROHN'S DISEASE BY USE OF BUCCAL MUCOSA

J. Walker, 1978, The Lancet.

Urinary excretion of ephedrine in man without pH control following oral administration of three commercial ephedrine sulfate preparations.

J. Wagner, P. Welling, J. Walker, 1971, Journal of pharmaceutical sciences.

Antibodies to vaccinia and measles viruses in multiple sclerosis patients.

K. Mcintosh, J. Burks, J. Walker, 1976, Archives of neurology.

A trial of antilymphocyte globulin in the treatment of chronic progressive multiple sclerosis

N. Kashiwagi, J. Walker, M. Hoehn, 1976, Journal of the Neurological Sciences.

Falls and fear of falling among elderly persons living in the community: occupational therapy interventions.

J Howland, J E Walker, J. Howland, 1991, The American journal of occupational therapy : official publication of the American Occupational Therapy Association.

A qualitative and quantitative evaluation of amantadine in the treatment of Parkinson's disease.

J E Walker, J. Albers, W. Tourtellotte, 1972, Journal of chronic diseases.

Simulated activities of daily living examination.

R W Pew, J E Walker, R. Pew, 1972, Archives of physical medicine and rehabilitation.

Plasma concentrations of propoxyphene in man. I. Following oral administration of the drug in solution and capsule forms.

J. Wagner, P. Welling, E. Sakmar, 1972, Internationale Zeitschrift fur klinische Pharmakologie, Therapie, und Toxikologie. International journal of clinical pharmacology, therapy, and toxicology.

Clinical studies of lorazepam in status epilepticus.

R. Homan, J. Walker, 1983, Advances in neurology.